Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells.
about
Rheumatoid factors from the peripheral blood of two patients with rheumatoid arthritis are genetically heterogeneous and somatically mutatedDo self-perpetuating B lymphocytes drive human autoimmune disease?Cell-cell interactions in synovitis: antigen presenting cells and T cell interaction in rheumatoid arthritis.B cells in rheumatoid arthritisSustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes.Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura.Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemiaAutoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodiesLupus nephritis: lessons from murine modelsHighly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants.From T to B and back again: positive feedback in systemic autoimmune disease.Genetic changes occurring in established tumors rapidly stimulate new antibody responsesCD5 negative IGM rheumatoid factor B cells in B-chronic lymphocytic leukemia and benign mixed cryoglobulinemia.Immunomodulation with antibodies: clinical application in ovarian cancer and other malignancies.Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion.Superantigen properties of a human sialoprotein involved in gut-associated immunity.Using antibodies in tumour immunotherapy.Structural bases of Fc gamma receptor functions.Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor.Prospects for B-cell-targeted therapy in autoimmune disease.Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG.Control of autoantibody affinity by selection against amino acid replacements in the complementarity-determining regionsB cells as a therapeutic target in autoimmune diseases.Human anti-immunoglobulin antibodies interfering in immunometric assays.Targeting autoantigen to B cells prevents the induction of a cell-mediated autoimmune disease in ratsThe interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patientsHuman immunoglobulin (IgG) induced deletion of IgM rheumatoid factor B cells in transgenic mice.Presentation of antigen in immune complexes is boosted by soluble bacterial immunoglobulin binding proteins.A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus.Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice.Role of repetitive antigen patterns for induction of antibodies against antibodies.Rheumatoid factors do not predict cardiovascular disease and mortality in the general population in the Busselton Health Survey.VH3-21 B cells escape from a state of tolerance in rheumatoid arthritis and secrete rheumatoid factorBiologic therapies for inflammatory eye disease.Epratuzumab (humanised anti-CD22 antibody) in autoimmune diseases.B lymphocytes as therapeutic targets in systemic lupus erythematosus.NK T cells provide lipid antigen-specific cognate help for B cellsCells of the synovium in rheumatoid arthritis. B cells.Rheumatoid arthritis and the complement system.Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice.
P2860
Q24608897-CA82C00C-B3A4-4945-9E7A-53A30B449E3AQ24642957-85ECB9D2-4BDE-4C0D-91B1-6FD3F11BFB6CQ24805227-50DC2FD0-225D-4951-8638-D4EE75EBCDDFQ24806825-6F6FC523-F3AD-4A4E-A6AB-3F34AB546B57Q33336433-30347BE6-74BD-4B5F-850B-243C89ECB354Q33418352-DCB99ECE-002D-4E19-B59C-DF841580857DQ33634440-C18B6F9F-7793-4002-91B5-66E344AD63A8Q33673310-B450E68D-9B54-46EF-93FF-F560649DEC11Q33998360-2A78BB16-4D9D-4933-B6B4-1BCC3C87DD6FQ34033969-5ACEE718-21A2-4CA2-8A31-8A27BEB636F5Q34572168-74CFF0A4-2F45-4B26-9D83-66C2CE902E6CQ34983184-B5500E10-0833-474E-ACFF-5B5C6DB01DC0Q35160039-0076901E-D93F-4334-9568-2EA703034055Q35195917-CA63F9DF-CB2C-4467-88F9-5AB794A76859Q35551028-BE12C164-D32B-42DD-90FC-C9830012C719Q35750821-AC82270E-05D5-4942-A5D7-B4E94483C825Q35842612-D2B7A82F-9EB5-4104-8B5E-239204CA7C1AQ35868443-28C76C1D-7BA0-4266-9AAF-40F9A8F651BFQ35907835-F43377CD-1ABE-4A77-B0B7-9F3F93919002Q35930307-4D2EC861-1FF6-4C02-BCE6-B6B5B0D71650Q35959398-DAE3C6ED-C60E-4389-BDAF-8539F29AD19FQ36012271-40FD0CE0-EE90-4878-9F6A-8D5C7DFAEE77Q36158684-AC53B23B-E51A-4A1C-8001-B64686A8ACB1Q36218992-A9805FA3-3178-4387-BC29-62B72C9C2383Q36230998-8E46E66A-5C8A-4CE1-A4AB-EE92B038A0F3Q36245889-55D5B1F9-C130-4DAF-945E-392AA53B9D16Q36364419-5567845E-17B5-4E8D-816E-A1E3E2460473Q36368050-C3AA9C86-BD5C-4F00-BC87-1EF5C52ACD74Q36369955-B2FA474D-E1E3-4FAC-B8FA-F3C8572C8D7BQ36375253-34F785C7-DB61-4266-A353-0E33C5FE1D45Q36377264-4C76942B-FCF0-427B-BACE-584C4790C300Q36383052-878DE9DB-7458-4538-9C2E-9B7A8253DD77Q36437639-2DDA10F5-254D-419D-8114-C33D9C2F6EA3Q36501675-E43A74DD-73B6-46AB-ACB2-C08DD455ECEFQ36569755-00781620-5F61-45C0-A152-5DB4CB488F6FQ36653646-1E0917FB-37BB-440B-9C96-3D9E8189767BQ36751506-3C2AC32F-B8AF-437D-9ED3-46FE40FC3794Q36755919-2D264D35-4357-4998-8E41-00CA0246345BQ36939396-3B5EB03F-68EF-4DFD-902F-84272BAFF43BQ37286418-61AFBD2E-6FE3-4D7C-8708-074C05C6BA87
P2860
Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Efficient and selective presen ...... by rheumatoid factor B cells.
@en
type
label
Efficient and selective presen ...... by rheumatoid factor B cells.
@en
prefLabel
Efficient and selective presen ...... by rheumatoid factor B cells.
@en
P2860
P356
P1476
Efficient and selective presen ...... by rheumatoid factor B cells.
@en
P2093
Lanzavecchia A
P2860
P304
P356
10.1084/JEM.173.2.487
P407
P577
1991-02-01T00:00:00Z